Yan-Yan Li1, Jing-Jing Wu2, Xin-Xing Yang1, Hong-Yu Geng1, Ge Gong1,3, Hyun Jun Kim4. 1. Department of Gerontology, First Affiliated Hospital of Nanjing Medical UniversityNanjing, China. 2. Department of Nephrology, First Affiliated Hospital of Nanjing Medical UniversityNanjing, China. 3. Department of Gerontology, Nanjing General HospitalNanjing, China. 4. Department of Physiology, University of CincinnatiCincinnati, OH, United States.
Abstract
Background: Although endothelial cell protein C receptor (EPCR) gene Ser219Gly polymorphism has been associated with venous thromboembolism (VTE) susceptibility, no clear consensus has yet been reached. Objective and methods: A meta-analysis of 9,494 subjects from 13 individual studies was conducted to better elucidate the potential relationship between the EPCR gene Ser219Gly polymorphism and VTE. Pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were evaluated by using fixed or random effect models. Results: The current meta-analysis suggested that there was a significant association between EPCR gene Ser219Gly polymorphism and VTE under allelic (OR: 1.42, 95% CI: 1.21-1.66, P = 1.30 × 10-5), recessive (OR: 2.02, 95% CI: 1.44-2.85, P = 5.35 × 10-5), homozygous (OR: 2.24, 95% CI: 1.59-3.16, P = 3.66 × 10-6), and additive genetic models (OR: 1.63, 95% CI: 1.30-2.04, P = 2.24 × 10-5). Conclusions:EPCR gene Ser219Gly polymorphism was associated with an elevated risk of VTE and the Gly residue carriers of the EPCR gene might be predisposed to VTE.
Background: Although endothelial cell protein C receptor (EPCR) gene Ser219Gly polymorphism has been associated with venous thromboembolism (VTE) susceptibility, no clear consensus has yet been reached. Objective and methods: A meta-analysis of 9,494 subjects from 13 individual studies was conducted to better elucidate the potential relationship between the EPCR gene Ser219Gly polymorphism and VTE. Pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were evaluated by using fixed or random effect models. Results: The current meta-analysis suggested that there was a significant association between EPCR gene Ser219Gly polymorphism and VTE under allelic (OR: 1.42, 95% CI: 1.21-1.66, P = 1.30 × 10-5), recessive (OR: 2.02, 95% CI: 1.44-2.85, P = 5.35 × 10-5), homozygous (OR: 2.24, 95% CI: 1.59-3.16, P = 3.66 × 10-6), and additive genetic models (OR: 1.63, 95% CI: 1.30-2.04, P = 2.24 × 10-5). Conclusions:EPCR gene Ser219Gly polymorphism was associated with an elevated risk of VTE and the Gly residue carriers of the EPCR gene might be predisposed to VTE.
Authors: S Uitte de Willige; V Van Marion; F R Rosendaal; H L Vos; M C H de Visser; R M Bertina Journal: J Thromb Haemost Date: 2004-08 Impact factor: 5.824